GlassScriptPhysician profile
John Fernandez
NPI 1316171408
$3,002.41
in general payments reported to CMS, 2019-2025
17 companies · $747 in 2025
The $747 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2021: $146 · 2022: $173 · 2023: $340 · 2024: $1,441 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $1,780 · Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $1,779.75 |
| Food and Beverage | $747.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $2,041.63 | 2021-2025 | Integra, Durasorb Monofilament Mesh, Surgimend |
| Mentor Worldwide LLC | $393.21 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Lilly USA, LLC | $77.52 | 2019 | |
| Smith+Nephew, INC. | $67.32 | 2019-2024 | Collagenase Santyl |
| Musculoskeletal Transplant Foundation INC. | $65.04 | 2023-2025 | |
| Allergan, INC. | $63.16 | 2019 | |
| Abbvie INC. | $55.58 | 2023-2024 | |
| Organogenesis INC. | $38.21 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $35.09 | 2021 | |
| Tela Bio, INC. | $27.36 | 2024 | Ovitex 2s |
| Davol INC. | $27.27 | 2021 | |
| Hartmann USA, INC. | $21.88 | 2022 | |
| Acera Surgical, INC. | $21.57 | 2024 | Restrata Wound Matrix |
| Sientra, INC. | $18.31 | 2022 | |
| Tactile Systems Technology INC | $17.61 | 2024 | Entre Plus, Flexitouch Plus |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $17.28 | 2023 | |
| Aroa Biosurgery Incorporated | $14.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.